Glenmark Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Glenmark Pharma	Glaxosmithkline Phar	Abbott India
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	13.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	25.0 .	n/a	n/a
Domestic Sales Growth - YoY	10.3 %	7.8 %	8.2 %
R&D as a % of Total Sales	7.3 %	0.07 %	0.02 %
Financials
5 yr Average ROE	3.99 %	40.73 %	30.11 %
5yr average Equity Multiplier	1.78	1.9	1.43
5yr Average Asset Turnover Ratio	0.8	0.94	1.14
5yr Avg Net Profit Margin	2.85 %	24.91 %	18.53 %
Price to Book	5.89	23.31	14.6
P/E	69.14	47.87	42.55
5yr Avg Cash Conversion Cycle	-150.94 Days	-107.65 Days	-46.68 Days
Inventory Days	32.28 Days	51.6 Days	45.22 Days
Days Receivable	32.34 Days	22.78 Days	19.34 Days
Days Payable	201.14 Days	144.46 Days	109.21 Days
5yr Average Interest Coverage Ratio	4.25	479.64	97.37
5yr Avg ROCE	17.54 %	44.44 %	38.77 %
5yr Avg Operating Profit Margin	15.96 %	25.23 %	23.42 %
5 yr average Debt to Equity	0.38	0.0	0.0
5yr CAGR Net Profit	1.54 %	20.96 %	15.41 %
5yr Average Return on Assets	2.09 %	21.84 %	21.03 %
Shareholdings
Promoter Holding	46.65 %	75.0 %	74.99 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	10.05 %	1.23 %	2.11 %

Business

	Glenmark Pharma	Glaxosmithkline Phar	Abbott India
Product Wise Break-Up	Product Wise Break-Up Branded Generics 60.46 Formulations 39.54 Vaccines 0 Pharmaceuticals 0 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Hormones 0 Anti Diabetic 0 Central Nervous System 0 Respiratory 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Women`s health 0 Gastro Intestinal 0 Pain 0	Product Wise Break-Up Vaccines 24.0 Anti-Infectives 0 Hepatoprotectives 0 cardiovascular system 0 Gastro Intestinal 0 Metabolic 0 Respiratory 0 Hormones 0 Central Nervous System 0 Vitamin, Minerals & Nutrition 0 Branded Generics 0 Pharmaceutical 76.0 Women`s health 0 Anti Diabetic 0 Formulations 0 Derma 0 Pain 0	Product Wise Break-Up Vaccines 0 Anti-Infectives 0 Hepatoprotectives 0 cardiovascular system 0 Gastro Intestinal 25.46 Metabolic 0 Respiratory 0 Hormones 11.59 Central Nervous System (CNS) 12.65 Vitamin, Minerals & Nutrition 0 Branded Generics 0 Pharmaceuticals 0 Women`s health 0 Anti Diabetic 42.82 Formulations 0 Derma 0 Pain 0 Others 7.48
Location Wise Break-Up	Location Wise Break-Up India 38.06 North America 23.88 Europe 20.5 Rest of the World 17.56 Latin America 0	Location Wise Break-Up Rest of the World 1.35 Europe 0 North America 0 India 98.65 Latin America 0	Location Wise Break-Up Rest of the World 1.19 Europe 0 North America 0 India 98.81 Latin America 0
Asset Break-Up	Asset Break-Up India 49.4 North America 42.56 Rest of the World 4.94 Europe 3.09 Latin America 0 Others 0.01	-	-

Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE